CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 76 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $143,000 | -41.2% | 209,198 | +3.0% | 0.00% | – |
| Q2 2023 | $243,000 | -0.4% | 203,198 | -2.9% | 0.00% | -100.0% |
| Q1 2023 | $244,000 | +58.4% | 209,198 | +7.6% | 0.00% | – |
| Q4 2022 | $154,000 | -25.2% | 194,485 | +14.0% | 0.00% | -100.0% |
| Q3 2022 | $206,000 | +31.2% | 170,623 | 0.0% | 0.00% | – |
| Q2 2022 | $157,000 | -59.6% | 170,623 | -21.6% | 0.00% | -100.0% |
| Q1 2022 | $389,000 | +47.9% | 217,623 | +27.5% | 0.00% | 0.0% |
| Q4 2021 | $263,000 | -24.2% | 170,623 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $347,000 | -41.3% | 170,623 | +0.4% | 0.00% | -50.0% |
| Q2 2021 | $591,000 | +95.0% | 169,944 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $303,000 | +74.1% | 169,944 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 169,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Avenue Asset Management, LP | 84,878 | $120,000 | 0.01% |
| DIMENSIONAL FUND ADVISORS LP | 13,938 | $20,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 2,000 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 21,000 | $29,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 7,229 | $10,000 | 0.00% |
| Citadel Advisors | 26,568 | $38,000 | 0.00% |
| Renaissance Technologies | 71,533 | $102,000 | 0.00% |
| Hilton Capital Management, LLC | 667 | $1,000 | 0.00% |
| VANGUARD GROUP INC | 110,976 | $158,000 | 0.00% |